India Biopharmaceutical Market worth INR 2892.5 billion 2023 with a CAGR of  9.8%.Highly skilled and experienced scientists who serve as a strong support system for the business process of the biopharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant centre for biopharmaceutical research and development (R&D), especially for vaccine manufacturing. Also, government action towards innovative program boosting bio-pharmaceutical production in the country.

The report " India Biopharmaceutical Market, By Type (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and, Others) and Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others) - Trends, Analysis and Forecast till 2030”. India Bio-pharmaceutical accounted for INR 2892.5 billion in 2023. 

Key Highlights:

• In February 2017, Cipla, Serum Institute launch Hepatitis B vaccine. Global CEO Umang Vohra said the agreement will enable Cipla to provide affordable vaccines for a chronic disease like Hepatitis B. Cipla's strong marketing network and reach will ensure maximum accessibility of the vaccines in India. 

Key Market Insights from the report:        

The India Biopharmaceutical market accounted for INR 2892.5 billion in 2023 and is projected to register a moderate CAGR of XX% over the forecast period. The market report has been segmented based on type, and application.

• By type, the monoclonal antibody segment dominated the global biopharmaceuticals market owing to the wide adoption of these drugs to treat chronic diseases, such as cancer. Furthermore, the surge in R&D concerning oncology drug development is also anticipated to boost the biopharmaceuticals market for monoclonal antibodies.
• By application, the India bio-pharmaceutical is segmented into oncology, a blood disorder, metabolic disease, infectious disease, cardiovascular disease, neurological disease, immunology, and other.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “India Biopharmaceutical Market”, By Type (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and, Others) and Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others), By Type (Rugged Barcode Scanners and Non-Rugged Barcode Scanners)- Trends, Analysis and Forecast till 2030

The prominent player operating in the India Biopharmaceutical market includes Bar Code India Limited, Bartronics India Limited, Honeywell Automation India Limited, Best IT World (India) Private Limited (iBall), Intex Technologies India Limited, Pegasus Technologies Private Limited, SATO Argox India Private Limited, TVS Electronics Limited.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions Development Company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com